title: Gene therapy for severe combined immune deficiency poised for European approval: If green-lighted, Strimvelis would provide additional treatment option for second most common form of disease.
mesh_terms: D000243:Adenosine Deaminase / Q000235:genetics; D005060:Europe; D015316:Genetic Therapy; D006801:Humans; D016511:Severe Combined Immunodeficiency / Q000628:therapy*
chemical_list: D000243:Adenosine Deaminase